Zen Leaf Enters New Jersey Medical Market with New Dispensary in Elizabeth

NEXT STORY
SIGA Technologies Announces First International Delivery of Oral TPOXX®
PREV STORY
Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nanobiotix reports successful results from Phase I/II Trial of NBTXR3 in Head & Neck Cancer

 Primary safety and feasibility endpoints achieved Preliminary positive signs of antitumoral effect in all ...

author_avatar
NASDAQ Market News

Invivoscribe® Receives FDA Approval for the LeukoStrat® CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt® and is the First Companion Diagnostic for AML

SAN DIEGO, April 28, 2017 (GLOBE NEWSWIRE) -- Invivoscribe® Technologies Inc., a global company ...

author_avatar
NASDAQ Market News

NanoVibronix Enters Collaboration Agreement with Fritz Clinic to Offer PainShield® as an Alternative to Opioids for Pain Management

ELMSFORD, N.Y., Jan. 11, 2019 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical ...

author_avatar
NASDAQ Market News